US HB326 | 2017-2018 | 115th Congress

Status

Spectrum: Partisan Bill (Democrat 1-0)
Status: Introduced on January 5 2017 - 25% progression, died in committee
Action: 2017-01-25 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]

Summary

Neuromyelitis Optica Consortium Act This bill amends the Public Health Service Act to require the National Institutes of Health to establish, administer, and coordinate a national consortium on neuromyelitis optica (NMO), which is a neurological disease that can cause blindness and paralysis. The consortium must: award grants for research on the causes of, and the risk factors and biomarkers associated with, NMO; assemble a panel of experts to provide guidance and recommendations on research design and protocols; and designate a central laboratory to collect and analyze data from this research and to make the data and analysis available to researchers.

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Neuromyelitis Optica Consortium Act

Sponsors


History

DateChamberAction
2017-01-25HouseReferred to the Subcommittee on Health.
2017-01-05HouseReferred to the House Committee on Energy and Commerce.
2017-01-05HouseIntroduced in House

Subjects


US Congress State Sources


Bill Comments

feedback